Development and implementation of a risk assessment tool for chemotherapy-induced neutropenia

Oncology Nursing Forum
Rebecca Donohue

Abstract

To evaluate a tool developed and implemented to help practitioners assess the risk of chemotherapy-induced neutropenia (CIN) and its complications in patients with nonleukemia cancer types. Retrospective survey of chart records. Community-based oncology practice. The medical records of 85 adult patients treated with new courses of chemotherapy, regardless of the cancer type or stage; 50 charts belonged to patients treated before the implementation of the tool and 35 to patients evaluated with the tool. A risk assessment tool for CIN that was developed using risk factors from published studies and national guidelines was implemented. Patients who were found to be at increased risk for CIN were given colony-stimulating factor (CSF) support starting with the first chemotherapy cycle. The effectiveness of the tool was evaluated by comparing clinical outcomes before and after the implementation of the risk assessment tool. Febrile neutropenia, IV antibiotic use, hospitalization for neutropenia, and chemotherapy dose reductions and delays. Chemotherapy dose delays, febrile neutropenia, treatment with IV antibiotics, and hospitalization for neutropenia occurred less frequently in patients assessed with the tool and managed with the al...Continue Reading

References

Jun 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L W KwakS J Horning
Jan 1, 1981·The New England Journal of Medicine·G Bonadonna, P Valagussa
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·V Trillet-LenoirD Tomita
Oct 14, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H OzerUNKNOWN American Society of Clinical Oncology
Dec 19, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M D GreenUNKNOWN International Pegfilgrastim 749 Study Group
Apr 17, 2003·Clinical Journal of Oncology Nursing·Carrie Tompkins Stricker, Jacqueline Sullivan
Dec 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gary H LymanJeffrey Crawford
May 26, 2004·Critical Reviews in Oncology/hematology·G H Lyman, N M Kuderer
Sep 24, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gary H LymanRichard I Fisher
Jan 22, 2005·Oncology Nursing Forum·Mary E RopkaTheresa W Gillespie
Feb 19, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles L VogelLee S Schwartzberg
Nov 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Johanna N Timmer-BonteVivianne C Tjan-Heijnen

❮ Previous
Next ❯

Citations

May 17, 2007·Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society·Libby Montoya
Feb 23, 2008·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Nora Kearney, Christopher Friese
Dec 3, 2013·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Catherine O'BrienM John Kennedy
Dec 7, 2006·Oncology Nursing Forum·Anita NirenbergRobert David Rice
Feb 2, 2010·Clinical Journal of Oncology Nursing·Irene Q Flores, William Ershler
Sep 8, 2016·Journal of Medical Economics·Dominick Latremouille-ViauChristopher Ngai
Jul 24, 2018·Clinical Journal of Oncology Nursing·Kathleen CliffordKaren Schiavo
Mar 7, 2006·Oncology Nursing Forum·Debra DeMilleLinda A Jacobs
Jun 23, 2006·Clinical Journal of Oncology Nursing·Kelley Moore, Debbie Crom
Jun 19, 2007·Oncology Nursing Forum·Grace Chu-Hui-Lin Chi
Jun 19, 2007·Oncology Nursing Forum·Gina D JohnsonBarry Fortner
Dec 8, 2007·Clinical Journal of Oncology Nursing·Keith MarinPaula Muehlbauer
Jun 3, 2018·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Auayporn NademaneeJohn Sweetenham
May 6, 2021·Revista brasileira de enfermagem·Rosilene Aparecida Costa AmaralKelli Borges Dos Santos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.